Fosun Pharmaceutical's Routine Transaction Amounts to 132 Million Yuan in First Nine Months

MT Newswires Live
2025/12/01

Shanghai Fosun Pharmaceutical's (SHA:600196, HKG:2196) total routine transaction for the first nine months of the year reached 132.7 million yuan, according to a Shanghai bourse disclosure on Saturday.

The pharmaceutical company's Hong Kong shares rose over 1% during Monday's afternoon trade.

The transactions include sales, provision and acceptance of services from related parties, leasing services and donations through related parties.

The estimated cap for the current year is 342.4 million yuan, while that for 2026 is 366.5 million yuan.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10